Acquire cell therapy manufacturing facility with clinical and commercial capabilitiesFurther ExacTcell platform for additional clinical trials based on successful completion of POCHighlight full year.
WARREN, N.J., April 03, 2024 Tevogen Bio Holdings Inc , a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development..